# Pharmacokinetics, Safety and Tolerability of Clascoterone Cream 1% in Healthy Chinese Adult Subjects

> **NCT06454708** · PHASE1 · COMPLETED · sponsor: **Zhejiang Sunshine Mandi Pharmaceutical Co.,Ltd.** · enrollment: 12 (actual)

## Conditions studied

- Acne Vulgaris

## Interventions

- **DRUG:** Clascoterone Cream 1%

## Key facts

- **NCT ID:** NCT06454708
- **Lead sponsor:** Zhejiang Sunshine Mandi Pharmaceutical Co.,Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-08-01
- **Primary completion:** 2024-08-12
- **Final completion:** 2024-08-12
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2025-01-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06454708

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06454708, "Pharmacokinetics, Safety and Tolerability of Clascoterone Cream 1% in Healthy Chinese Adult Subjects". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06454708. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*